Fundraising Fox

PrimeGen Biotech

Santa Ana, US · Delaware LLC

Founders & leadership

TC
Thomas C.K. YuenManager and Chief Executive Officer

Board

SD
Steven D. GershickManager
WS
Wai SzetoManager

Reported raises · per SEC filings

Form D private placements

$22.5M disclosed across 6 rounds · 2014–2016

$400KraisedAug 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven D. GershickDirector
  • Thomas C.K. YuenExecutive Officer, Director
  • Lenard MakowkaDirector
  • Wai Sun SzetoDirector
Offering amount
$400K
Amount sold
$400K
First sale
Jul 2016
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.7MraisedMay 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wai Sun SzetoDirector
  • Lenard MakowkaDirector
  • Thomas C.K. YuenExecutive Officer, Director
  • Steven D. GershickDirector
Offering amount
$1.7M
Amount sold
$1.7M
First sale
Dec 2015
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedJan 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wai Sun SzetoDirector
  • Steven D. GershickDirector
  • Thomas C.K. YuenExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
First sale
Oct 2015
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$450KraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas C.K. YuenExecutive Officer, Director
  • Steven D. GershickDirector
  • Wai SzetoDirector
Offering amount
$450K
Amount sold
$450K
First sale
Jul 2015
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.4MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven D. GershickDirector
  • Wai SzetoDirector
  • Thomas C.K. YuenExecutive Officer, Director
Offering amount
$1.4M
Amount sold
$1.4M
First sale
Apr 2015
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$17.6MraisedAug 2014 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas C.K. YuenExecutive Officer, Director
  • Wai SzetoDirector
  • Steven GershickDirector
Offering amount
$17.6M
Amount sold
$17.6M
First sale
Aug 2014
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has PrimeGen Biotech raised?
PrimeGen Biotech has disclosed $22.5M raised across 6 rounds.
Where is PrimeGen Biotech headquartered?
PrimeGen Biotech is headquartered in Santa Ana, US.